Patent: 5,606,040
✉ Email this page to a colleague
Summary for Patent: 5,606,040
| Title: | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
| Abstract: | This disclosure describes disulfide analogs of the family of antibacterial and antitumor agents known collectively as the LL-E33288 complex. |
| Inventor(s): | William J. McGahren, Martin L. Sassiver, George A. Ellestad |
| Assignee: | Wyeth Holdings LLC |
| Application Number: | US08/155,179 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,606,040
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Wyeth Pharmaceuticals Llc | MYLOTARG | gemtuzumab ozogamicin | For Injection | 761060 | 1-Sep-17 | 5,606,040 | 2014-02-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
